Business
Clorox Reports Q3 Fiscal Year 2025 Results, Updates Outlook
The Clorox Company (NYSE: CLX) today reported results for the third quarter of fiscal year 2025, which ended Mar. 31, 2025.
About this update from Clorox Company (the)
[{"type":"text","content":"Delivers lower-than-expected sales amid a challenging and volatile consumer and geopolitical environment while maintaining overall market shares and delivering its 10th consecutive quarter of gross margin expansion","length":214,"tagName":"p"},{"type":"text","content":"OAKLAND, Calif., May 5, 2025 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today reported results for the third quarter of fiscal year 2025, which ended Mar. 31, 2025.","length":173,"tagName":"p"},{"type":"text","content":"Third-Quarter Fiscal Year 2025 Summary","length":38,"tagName":"p"},{"type":"text","content":"Following is a summary of key results for the third quarter, which reflect the prior divestitures of the Better Health Vitamins, Minerals and Supplements (VMS) and Argentina businesses. All comparisons are with the third quarter of fiscal year 2024 unless otherwise stated.","length":273,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net sales decreased 8% to $1.67 billion, primarily driven by the divestitures of the VMS and Argentina businesses. Organic sales1 decreased 2%, primarily driven by unfavorable price mix. Organic volume was flat, primarily impacted by consumption slowdown across most of its businesses.","length":285,"tagName":"p"}]},{"val":[{"type":"text","content":"Gross margin increased 240 basis points to 44.6% from 42.2% in the year-ago quarter, primarily driven by cost savings and the benefits from the divestitures of the VMS and Argentina businesses.","length":193,"tagName":"p"}]},{"val":[{"type":"text","content":"Diluted net earnings (losses) per share (diluted EPS) increased 466% to $1.50 from a loss of $0.41 in the year-ago quarter. The increase includes lapping the loss relating to the divestiture of the Argentina business and the current-period benefit of cyberattack insurance recoveries.","length":284,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EPS1 decreased 15% to $1.45 from $1.71 in the year-ago quarter, primarily due to lower net sales, partially offset by higher gross margin.","length":152,"tagName":"p"}]},{"val":[{"type":"text","content":"Year-to-date net cash provided by operations was $687 million compared to $355 million in the year-ago period, representing a 94% increase.","length":139,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":1053,"olType":false},{"...